When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Thinly traded micro cap XBiotech (XBIT+13.4%) is up on over triple normal volume, albeit on turnover of only 484K shares, on the heels of positive results from a Phase 2 clinical trial evaluating bermekimab in patients with moderate-to-severe atopic dermatitis (AD). The data will be presented tomorrow at the American Academy of Dermatology Annual Meeting in Washington, DC.
More news on: Xbiotech, Regeneron Pharmaceuticals, Inc., Sanofi, Healthcare stocks news, Stocks on the move,